title: High plasma concentrations of osteopontin in patients with interstitial pneumonia.
abstract: Osteopontin (OPN) produced by alveolar macrophages functions as a fibrogenic cytokine in the development of bleomycin (BLM)-induced murine pulmonary fibrosis, and OPN mRNA is expressed on lung tissues from patients with idiopathic pulmonary fibrosis (IPF). The present study investigates plasma OPN levels in human interstitial pneumonia (IP) and their relationships with disease severity by analyzing the correlation between plasma OPN concentrations and pulmonary functions. The concentrations of OPN in plasma were measured in 17 patients with IP, in 9 with sarcoidosis and in 20 healthy controls using an antigen-capture enzyme-linked immunosorbent assay. The concentrations of OPN in plasma were significantly higher in IP patients than in those with sarcoidosis or in controls. Based on a Receiver Operating Characteristic curve analysis, cut-off points between 300 and 380 ng/ml discriminated between IP and control subjects with 100% sensitivity and 100% specificity. In such case, the sensitivity for sarcoidosis decreased (55.5-33.3%) in cut-offs with 100% specificity. Plasma OPN levels inversely and closely correlated with arterial oxygen tension (PaO2) in patients with IP. Immunohistochemically, OPN was localized predominantly in macrophages and airway epithelium. These findings suggest that plasma OPN levels were found to be associated with the presence of IP, and that OPN play an important role in the development of IP.
authors.affiliation: Division of Pathogenesis and Disease Control, Department of Infectious Diseases, Faculty of Medicine, Oita University, 1-1 Hasama, Oita 879-5593, Japan. kadota@med.oita-u.ac.jp
authors.forename: J
authors.initials: J
authors.lastname: Kadota
authors.forename: S
authors.initials: S
authors.lastname: Mizunoe
authors.forename: K
authors.initials: K
authors.lastname: Mito
authors.forename: H
authors.initials: H
authors.lastname: Mukae
authors.forename: S
authors.initials: S
authors.lastname: Yoshioka
authors.forename: K
authors.initials: K
authors.lastname: Kawakami
authors.forename: Y
authors.initials: Y
authors.lastname: Koguchi
authors.forename: K
authors.initials: K
authors.lastname: Fukushima
authors.forename: S
authors.initials: S
authors.lastname: Kon
authors.forename: S
authors.initials: S
authors.lastname: Kohno
authors.forename: A
authors.initials: A
authors.lastname: Saito
authors.forename: T
authors.initials: T
authors.lastname: Uede
authors.forename: M
authors.initials: M
authors.lastname: Nasu
mesh_terms: D000328:Adult; D000368:Aged; D015415:Biomarkers / Q000097:blood; D002248:Carbon Monoxide / Q000378:metabolism; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques; D017563:Lung Diseases, Interstitial / Q000097:blood* / Q000378:metabolism / Q000503:physiopathology; D016676:Macrophages, Alveolar / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D053495:Osteopontin; D010100:Oxygen / Q000097:blood; D010313:Partial Pressure; D017565:Sarcoidosis, Pulmonary / Q000097:blood; D012680:Sensitivity and Specificity; D012795:Sialoglycoproteins / Q000097:blood* / Q000378:metabolism / Q000502:physiology; D014797:Vital Capacity
chemical_list: D015415:Biomarkers; C506895:SPP1 protein, human; D012795:Sialoglycoproteins; D053495:Osteopontin; D002248:Carbon Monoxide; D010100:Oxygen